Bagsvaerd, Denmark, April 1, 2014 (GLOBE NEWSWIRE) -- In continuation of the company’s announcements dated 31 October 2013 and 30 January 2014 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE:NVO) and its wholly-owned affiliates on 31 March 2014 owned 114,201,901 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 22,840,380 or 4.2% of the total share capital.
Help employers find you! Check out all the jobs and post your resume.
